Parkinson's Disease in Home Rehabilitation Services

April 18, 2022 updated by: María Cruz Sousa Fraguas, University of Oviedo

Clinical-epidemiological Characteristics of Patients With Parkinson's Disease Referred to a Home Rehabilitation Service

Introduction: Home rehabilitation is a form of care that is part of most health systems. Patients with Parkinson's disease can be referred to these Home Rehabilitation Services given the characteristics of the pathology they suffer.

Objective: know and analyse the clinical-epidemiological characteristics of patients with Parkinson's disease referred to a Home Rehabilitation Service belonging to health Area V of Gijón, Asturias, Spain.

Study Design: This project proposes an observational and retrospective study.

Study population: The subjects that will be part of this study will be men and women with Parkinson's disease who have been referred to the Home Rehabilitation Service from 2015 to 2021.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Introduction:

Home-based rehabilitation is a care modality that is part of most healthcare systems. In most cases, patients are referred from hospitals, by the rehabilitation services themselves or by the specialist physicians who have treated them. Patients who may be candidates for home rehabilitation often have difficulties in accessing a hospital or outpatient centre independently, due to difficulty in walking and/or architectural barriers within or outside the home, so that in order to travel to outpatient centres, they need means of transport such as ambulances, which entails high costs. Patients with Parkinson's Disease can be referred to these Home Rehabilitation Services.

Objectives:

General:

Know and analyse the clinical-epidemiological characteristics of patients with Parkinson's Disease referred to a Home Rehabilitation Service belonging to the Health Area V of Gijón.

Specific:

Assess the distribution of patients by age group, sex, social conditions and degree of functional impairment.

Find out the time needed for recovery or completion of treatment, as well as the criteria for discharge.

Obtain information on the social assessment and architectural barriers of Parkinson's disease patients referred to a Home Rehabilitation Service.

Study design:

The present project proposes to carry out an observational, ex post facto, retrospective study.

The subjects who will be part of this study will be men and women with Parkinson's disease who have been referred to the Home Rehabilitation Service from 2015 to 2021. Available data from the entire population of patients with Parkinson's disease who meet the inclusion criteria will be analysed.

Limitations:

The limitations of the present study are that the patients will be analysed within a specific setting, such as a Home Rehabilitation Service, so it is possible that some results cannot be generalized.

Study Type

Observational

Enrollment (Actual)

145

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with Parkinson's disease

Description

Inclusion Criteria:

  • Men and women with Parkinson's disease
  • Patients belonging to Health Area V of the Health System of the Principality of Asturias, Spain.
  • Subjects who have been referred at some point to home rehabilitation.

Exclusion Criteria:

- Patients who have been discharged at the first medical visit.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Observational group
Patients with Parkinson's disease who were referred to a Home Rehabilitation Service in Gijón, Asturias region, Spain, during the years 2015 to 2021.
Patients received physiotherapy treatment at home for a certain period of time. Data were collected on the assessments made at the beginning and at the end of the physiotherapy treatment.
Other Names:
  • Physiotherapy treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnosis:
Time Frame: Baseline
The specific diagnosis of Parkinsonian syndrome presented by each patient.
Baseline
Epidemiological characteristics
Time Frame: Baseline
Age, this variable will be measured in years. Sex will be recorded as male and female. Social assessment: the following data will be recorded: Place of residence: whether the patient lives alone at home, with his or her family or in a geriatric centre. Existence or non-existence of a caregiver, if so, whether it is formal or informal. Housing suitable for the patient's needs or not. Finally, comorbidities: according to the Charlson comorbidity index, considering absence of comorbidity between 0 and 1 points, low comorbidity 2 points, high comorbidity between 3 and 5 points and severe comorbidity over 5 points.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Barthel index
Time Frame: Baseline to end of treatment (up to 3 months)
Functional independence was measured by the Barthel Index. It has a total score ranging from 0 to 100, where 0 is the minimum (worst outcome) and 100 is the maximum (best outcome).
Baseline to end of treatment (up to 3 months)
Pain intensity
Time Frame: Baseline to end of treatment (up to 3 months)
Numerical visual analogue pain measurement scale. The patient must assign a numerical value to the pain between two extreme points (0 no pain, to 10 the worst pain imaginable), the higher the score the greater the pain experienced.
Baseline to end of treatment (up to 3 months)
Gait assessment
Time Frame: Baseline to end of treatment (up to 3 months)
Gait ability measured according to Holden's Gait Classification (FAC). This scale ranges from 0 (no gait) to 5 (independent gait including walking up and down stairs). The higher the score, the better the gait performance.
Baseline to end of treatment (up to 3 months)
Reason for discharge
Time Frame: End of treatment (up to 3 months)

Can be the following options:

  • The value of the Barthel index reached at the end of treatment.
  • Chronicity.
  • Referral to outpatient rehabilitation.
  • Change of residence.
  • Voluntary discharge.
  • Hospital admission.
  • Worsening without hospital admission.
  • Exitus.
End of treatment (up to 3 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: María Cruz Sousa-Fraguas, University of Oviedo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

April 1, 2022

Study Completion (Actual)

April 13, 2022

Study Registration Dates

First Submitted

April 12, 2022

First Submitted That Met QC Criteria

April 18, 2022

First Posted (Actual)

April 22, 2022

Study Record Updates

Last Update Posted (Actual)

April 22, 2022

Last Update Submitted That Met QC Criteria

April 18, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on physiotherapy

3
Subscribe